R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins. It’s the first part of what the company describes will grow to become a ...
Wall Street’s sell-off of enterprise software stocks resumed in earnest late last week, sending stocks such as ServiceNow and ...
Acquisition of Dotmatics, a leader in Life Sciences R&D software for $5.1 billion Expands Siemens' market-leading position in industrial software by extending AI-powered Product Lifecycle Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results